Vaccine Manufacturing Articles - BioPharm International

ADVERTISEMENT

Vaccine Manufacturing Articles

EMA Works to Speed Up Ebola Treatment

October 20, 2014

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

Challenges in Biologic Drug and Vaccine Delivery

October 1, 2014

Prefilled syringes offer advantages to manufacturers, healthcare professionals, and patients.

Biopharma Manufacturers Respond to Ebola Crisis

October 1, 2014

Demand for new therapies and vaccines spotlights production challenges.

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

September 26, 2014

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

FDA Licenses First US Facility for Cell-Culture Influenza Vaccines

June 16, 2014

Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.

Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions

May 1, 2014

New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.

Regulatory Requirements for Viral-Challenge Studies: Influenza Case Study

May 1, 2014

Review regulatory requirements and the use of viral-challenge studies in drug development.

FDA Details National Vaccine Plan

March 11, 2014

HHS plan makes progress in ensuring availability of safe vaccines.

European Medicines Agency Updates Seasonal Flu Vaccine Guidance

February 11, 2014

EMA releases an update on its flu vaccine guidance.

ADVERTISEMENT

ADVERTISEMENT

Click here